# US 2010/0167979 A1 · Rheumatoid arthritis-preventive agent for oral intake

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167979 A1
- Document ID: US20100167979A1
- Status: Published application
- Kind: A1
- Application number: 12/278,880
- Filed: 2007-02-09
- Published: 2010-07-01
- Earliest claimed: 2006-02-09
- Assignees: Calpis Co., Ltd.
- Inventors: Michio Hatori; Kohji Ohki; Naomi Hashimura; Tatsuhiko Hirota; Kazuhito Ohsawa
- Web page: https://patentgrep.com/patent/US20100167979A1

## CPC

- A61K 38/018: {from milk}
- A23L 33/175: Amino acids
- A23L 33/18: Peptides; Protein hydrolysates
- A23L 33/19: Dairy proteins
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 35/20: Milk; Whey; Colostrum
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

There is provided a rheumatoid arthritis inhibitor for oral intake that has an inhibitory effect on rheumatoid arthritis and is excellent in safety. The rheumatoid arthritis inhibitor for oral intake of the present invention contains, as an active component, a casein hydrolysate containing free amino acids and peptides obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, or a mixture of free amino acids and peptides contained in the hydrolysate.

## Claims

### Claim 1

A rheumatoid arthritis inhibitor for oral intake comprising, as an active component, a casein hydrolysate comprising free amino acids and peptides obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, or a mixture of free amino acids and peptides contained in said hydrolysate.

### Claim 2 (depends on 1)

The rheumatoid arthritis inhibitor according to claim 1, wherein said casein hydrolysate is a product of enzymatic digestion of animal milk casein with an enzyme derived from Aspergillus.
